Bill

Bill > SR84


NJ SR84

NJ SR84
Urges relevant State licensing boards to implement continuing education requirements on topics related to opioid pain medication.


summary

Introduced
03/18/2024
In Committee
03/18/2024
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

This resolution urges the State Boards of Medical Examiners, Dentistry, Nursing, and Pharmacy to implement continuing education requirements on topics related to opioid pain medication, including responsible prescribing practices, alternatives to opioid medication for managing and treating pain, and the risks and signs of opioid misuse, abuse, and addiction. The boards are also urged to ensure that the continuing education requirements would remain in effect for the next biennial period for the renewal of professional licenses, registrations, or certifications, unless the time period is extended by the boards, and apply to physicians, physician assistants, advance practice nurses, dentists, pharmacists, professional nurses, practical nurses, and other health care professionals with the authority to prescribe opioid pain medication and those who do not have prescribing authority but frequently interact with patients who may be prescribed opioids.

AI Summary

This resolution urges the State Boards of Medical Examiners, Dentistry, Nursing, and Pharmacy to implement mandatory continuing education requirements for healthcare professionals specifically focused on opioid pain medication. The proposed continuing education would cover critical topics including responsible prescribing practices, alternative pain management strategies, and comprehensive education about the risks and signs of opioid misuse, abuse, and addiction. The requirements would apply to a broad range of healthcare professionals who either have the authority to prescribe opioid medications (such as physicians, physician assistants, advance practice nurses, dentists, and pharmacists) or who frequently interact with patients who might be prescribed opioids. The resolution recommends that these continuing education requirements remain in effect for two biennial licensing periods, unless the boards choose to extend the timeframe. This resolution is contextualized by preceding whereas clauses that highlight the significant opioid prescription rates in the United States, the lack of long-term research on opioid effectiveness, and the serious risks associated with opioid pain medication use, ultimately aiming to improve healthcare professionals' understanding and management of opioid prescriptions.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 03/18/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...